Showing results (601-610 of 3,921) with videos related to

Sort By:
Pageof 393
European Journal of Gynaecological Oncology|February 24, 2001
Invasive condylomatous vulvar carcinoma associated with multifocal low genital tract neoplasia. A case reportS Djurdjevic, Z Janjic, B Hadzic, et al.
European Journal of Gynaecological Oncology|February 24, 2001
Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams UniversityI K El-Lamie, N A Shehata, S K Abou-Loz, et al.
European Journal of Gynaecological Oncology|February 24, 2001
Usefulness of PCR in situ hybridization as a technique for morphological detection of human papillomavirus in uterine cervical neoplasiaT Oguchi, S Sato, Y H Xiao, et al.
European Journal of Gynaecological Oncology|February 24, 2001
Primary malignant lymphoma of the ovary: an unusual presentation of a rare diseaseH Mansouri, H Sifat, M Gaye, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Signal transduction and biochemical targeting of ovarian carcinomaG Weber, D F Shen, W Li, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Quantitative detection of oncogenic HPV DNA using hybrid capture to triage borderline and mildly dyskaryotic Papanicolaou smearsT A Mould, A Singer, S Gallivan
European Journal of Gynaecological Oncology|August 19, 2000
Margin clearance and HPV infection do not influence the cure rates of early neoplasia of the uterine cervix by laser conizationT Izumi, N Kyushima, T Genda, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Cervicography to triage women with borderline or mild dyskaryotic cervical PAP smearsT A Mould, A Singer, M E Mansell, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Prognostic significance of deletion and over-expression of the p53 gene in epithelial ovarian cancerS S Ozalp, O T Yalcin, G N Basaran, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Effect of adjuvant chemotherapy using pirarubicin, cisplatin, and etoposide (PEP) for stage IVB endometrial carcinoma: a case reportN Umesaki, T Tanaka, M Miyama, et al.
Pageof 393